Interferon Alfa-n3 clinical trials
- studies test it
- 5
- open now
- 0
- in phase 3
- 0
- first study started
- 2004
How each study uses Interferon Alfa-n3 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 10 Oct 1989 · ALFERON N INJECTION · BLA 103158 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
2 studies that test it; most in 2004 (1)
| Year | Studies |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 5 · Other 0
AIM ImmunoTech Inc. (2) · Interferon Sciences (2) · Purdue Frederick (1)
Related medicines
As reviewed, each with the page that says it.
- One of Interferon Alpha source
Studies
Open first, then newest update. How each study uses Interferon Alfa-n3 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- A Randomized, Dose-ranging Study of Alferon LDO in Asymptomatic HIV+ SubjectsTerminatedPhase 2AIM ImmunoTech Inc.NCT00215852Written as Alferon LDO
- Study of Alferon® LDO (Low Dose Oral) in Normal VolunteersCompletedPhase 2AIM ImmunoTech Inc.NCT00215826Written as Alferon LDO
- Double-Blind, Randomized, Placebo-Controlled Study of Low Dose Oral Interferon Alfa-n3 (Human Leukocyte Derived) in ARC PatientsCompletedNot applicableInterferon SciencesNCT00002012Written as Interferon alfa-n3
- Double-Blind, Randomized, Dose Ranging Study of Alferon LDO (Low Dose Oral Interferon Alfa-n3 (Human Leukocyte Derived)) in HIV+ SubjectsCompletedNot applicableInterferon SciencesNCT00002018Written as Interferon alfa-n3
- Phase I Study of Alferon N Injection in Persons With Asymptomatic Human Immunodeficiency Virus (HIV) InfectionCompletedPhase 1Purdue FrederickNCT00002078Written as Interferon alfa-n3
Codes
What other systems call Interferon Alfa-n3 · ClinicalTrials.gg INT005750
- MeSH (NLM) C554126Interferon Alfa-n3One source NLM
- UNII (FDA) 47BPR3V3MPINTERFERON ALFA-N3Confirmed FDA, NLM, Wikidata
- Wikidata Q6046446interferon alfa-n3Confirmed FDA, NLM, Wikidata
- NCI Thesaurus C30136Interferon Alfa-N3One source FDA
- DrugBank DB00018One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C554126 | Interferon Alfa-n3 | One source NLM |
| UNII (FDA) | 47BPR3V3MP | INTERFERON ALFA-N3 | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q6046446 | interferon alfa-n3 | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C30136 | Interferon Alfa-N3 | One source FDA |
| DrugBank | DB00018 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.